CompletedNot Applicable

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

France682 participantsStarted 2015-07

Plain-language summary

Exploratory study on blood-borne biological markers and their correlation with clinical and pathological characteristics.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patient with any tumoral disease (proven or suspected), of any type and stage
✓. More than18 years old
✓. Signed informed consent form
✓. Tumor considered as accessible by biopsy
✓. Normal blood coagulation tests on the last blood analysis
✓. Patient in detention or protected by the law
✓. Patient who cannot comply with the study follow up for geographical, social or psychological reasons
✓. Anticoagulant or antiaggregant that cannot be interrupted for the biopsy

Feasibility of the analysis of different blood-borne tumor biomarkers

Timeframe: 18 months

NCT IDNCT02866149

SponsorInstitut Curie

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07